Home › Funds › NAN FUNG TRINITY (HK) Ltd › KURA
NAN FUNG TRINITY (HK) Ltd position in KURA
KURA ONCOLOGY INC · Health Care
NAN FUNG TRINITY (HK) Ltd reported holding 1,174,880 shares of KURA (KURA ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$12.6M, representing 1.21% of its reported portfolio and ranking #35 among its reported holdings. NAN FUNG TRINITY (HK) Ltd has disclosed KURA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NAN FUNG TRINITY (HK) Ltd's KURA position evolved
NAN FUNG TRINITY (HK) Ltd first disclosed a stake in KURA in Q3 2025 at 230,880 shares (US$2.0M). The position peaked in Q2 2026 at 1,174,880 shares, worth US$12.9M. Across 5 filings, NAN FUNG TRINITY (HK) Ltd increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,174,880 shares valued at US$12.6M. Notable position changes include a 318% increase in Q4 2025 (shares fell 22% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 230.88K | $2.04M | New |
| Q4 2025 | 964.88K | $10.03M | Add |
| Q1 2026 | 1.06M | $8.66M | Add |
| Q2 2026 | 1.17M | $12.89M | Add |
| Q3 2026 | 1.17M | $12.58M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KURA and 13F data
KURA (KURA ONCOLOGY INC) is a Health Care company. 26 other funds we track also report a position in KURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$94.1M), BVF INC/IL (US$92.7M), ARMISTICE CAPITAL, LLC (US$40.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KURA
- MONTANOVA CAPITAL, LLC 8.58M sh · $94.07M · Q2 2026
- BVF INC/IL 8.45M sh · $92.65M · Q2 2026
- ARMISTICE CAPITAL, LLC 3.68M sh · $40.35M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 2.18M sh · $23.30M · Q3 2026
- Prosight Management, LP 2.02M sh · $22.18M · Q2 2026
More on NAN FUNG TRINITY (HK) Ltd
FAQ
How long has NAN FUNG TRINITY (HK) Ltd held KURA?
NAN FUNG TRINITY (HK) Ltd has disclosed KURA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is NAN FUNG TRINITY (HK) Ltd's current position in KURA?
As of Q3 2026, NAN FUNG TRINITY (HK) Ltd holds 1.17M shares of KURA (KURA ONCOLOGY INC), valued at $12.58M, representing 1.21% of its reported portfolio and ranking #35.
Has NAN FUNG TRINITY (HK) Ltd been buying or selling KURA?
In the latest 13F filing (Q3 2026), NAN FUNG TRINITY (HK) Ltd held unchanged its position in KURA. The position peaked in Q2 2026 at 1.17M shares.
Which other funds hold KURA?
Other major institutional holders of KURA include MONTANOVA CAPITAL, LLC, BVF INC/IL, ARMISTICE CAPITAL, LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.